PAIN
Volume 147, Issue 1 , Pages 5-6 , 15 December 2009

Topical analgesic medication – The dawn of a new era

References 

  1. Argoff C. Topical agents for the treatment of chronic pain. Curr Pain Headache Rep. 2006;10:11–19
  2. Argoff CE, Albrecht P, Irving G, Rice F. Multimodal analgesia for chronic pain: rationale and future directions. Pain Med. 2009;10:S53–S66
  3. Cao JL, Ruan JP, Ling DY, Guan XH, Bao Q, Yuan Y, et al. Activation of peripheral ephrinBs/EphBs signaling induces hyperalgesia through a MAPKs-mediated mechanism in mice. Pain. 2008;139:617–631
  4. Dong XD, Svensson P, Cairns BE. The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism. Pain. 2009;147:36–45
  5. Matthews P, Derry S, Moore RA, McQuay HJ. Topical rubefacients for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;8:CD007403
  6. Zhao P, Barr TP, Hou Q, Dib-Hajj SD, Black JA, Albrecht PJ, et al. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain. 2008;139:90–105

PII: S0304-3959(09)00529-6

doi: 10.1016/j.pain.2009.09.010

PAIN
Volume 147, Issue 1 , Pages 5-6 , 15 December 2009

Article Tools